Summary
Median Technologies SA (Median Technologies) is a medical technology company that develops and markets medical imaging solutions. The company's offers eyonis, an artificial intelligence (AI) and machine learning (MI) based CADx (computer-aided diagnosis) software as medical device (SaMD) used for the early detection, screening and treatment of lung and liver cancers. The company also provide iSee Viewer and iSee Portal platform for managing and analyzing medical imaging data. Median Technologies offering services including oncology clinical trials imaging services and core lab imaging services. It serves to biopharma companies, CROs, health professionals and patients. The company operates in the US, China and France. Median Technologies is headquartered in Valbonne, Provence - Alpes- Cote d'Azur, France.This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Median Technologies SA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Median Technologies SA Company Overview
- Median Technologies SA Company Snapshot
- Median Technologies SA Pipeline Products and Ongoing Clinical Trials Overview
- Median Technologies SA - Pipeline Analysis Overview
- Median Technologies SA - Key Facts
- Median Technologies SA - Major Products and Services
- Median Technologies SA Pipeline Products by Development Stage
- Median Technologies SA Pipeline Products Overview
- eyonis - IPN
- eyonis - IPN Product Overview
- Eyonis LCS
- Eyonis LCS Product Overview
- Liver Cancer CADe
- Liver Cancer CADe Product Overview
- Liver Cancer CADx
- Liver Cancer CADx Product Overview
- Liver Disease (NAFLD/NASH) De/Dx
- Liver Disease (NAFLD/NASH) De/Dx Product Overview
- Pheno iDx HCC Recurrence
- Pheno iDx HCC Recurrence Product Overview
- Pheno iDx Liver
- Pheno iDx Liver Product Overview
- Pheno iDx NASH
- Pheno iDx NASH Product Overview
- Median Technologies SA - Key Competitors
- Median Technologies SA - Key Employees
- Median Technologies SA - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Median Technologies SA, Recent Developments
- May 29, 2024: Median Technologies to Participate in the 2024 ASCO Annual Meeting, May 31 - June 4, 2024, McCormick Place, Chicago, IL, USA
- May 21, 2024: Median Technologies, a World Leading Oncology Clinical Trial Imaging Services Provider, Becomes Preferred Vendor to Another Top 3 Pharmaceutical Company
- Feb 26, 2024: Median Technologies to Participate and Speak at the 2024 European Congress of Radiology (ECR), February 28 - March 3, Vienna, Austria
- Dec 14, 2023: Median Technologies and PASREL-Imagerie Join Forces to Deliver Smart Imaging Biomarkers Supporting the Development of New Oncology Drugs in Precision Medicine
- Nov 30, 2023: Median Technologies to Speak at the IASLC 2023 North America Conference on Lung Cancer (NACLC), Dec. 1-3, Chicago, IL, USA, with Two Presentations
- Nov 27, 2023: Median Technologies Selected for Support Under the French Government's ETIncelles Program
- Nov 26, 2023: Median Technologies Announces Rebranding of iBiopsy, Changes Name to eyonis
- Oct 17, 2023: First Results of Median Technologies’ iBiopsy HCC Detection AI Model Developed on the PHELICAR Clinical Data Registry, to Be Presented at the ESMO Congress (Oct 20-24, 2023, Madrid, Spain)
- Oct 16, 2023: Median Technologies’ Global iCRO Team to participate in the 2023 ESMO Congress, Oct 20 - 24, 2023, Madrid, Spain
- Feb 27, 2023: Median Technologies announces completion of the Q-Submission phase with the FDA for its iBiopsy lung cancer screening CADe/CADx software as medical device
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Median Technologies SA Pipeline Products and Ongoing Clinical Trials Overview
- Median Technologies SA Pipeline Products by Equipment Type
- Median Technologies SA Pipeline Products by Indication
- Median Technologies SA, Key Facts
- Median Technologies SA, Major Products and Services
- Median Technologies SA Number of Pipeline Products by Development Stage
- Median Technologies SA Pipeline Products Summary by Development Stage
- eyonis - IPN - Product Status
- eyonis - IPN - Product Description
- Eyonis LCS - Product Status
- Eyonis LCS - Product Description
- Liver Cancer CADe - Product Status
- Liver Cancer CADe - Product Description
- Liver Cancer CADx - Product Status
- Liver Cancer CADx - Product Description
- Liver Disease (NAFLD/NASH) De/Dx - Product Status
- Liver Disease (NAFLD/NASH) De/Dx - Product Description
- Pheno iDx HCC Recurrence - Product Status
- Pheno iDx HCC Recurrence - Product Description
- Pheno iDx Liver - Product Status
- Pheno iDx Liver - Product Description
- Pheno iDx NASH - Product Status
- Pheno iDx NASH - Product Description
- Median Technologies SA, Key Employees
- Median Technologies SA, Other Locations
- Median Technologies SA, Subsidiaries
- Glossary
- Median Technologies SA Pipeline Products by Equipment Type
- Median Technologies SA Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Therapixel SA
- Quantificare SA
- Intrasense SA
- IntegraGen SA
- EOS Imaging SA
